Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 24, Iss. 4, 2008-01 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite

The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis

By Karadag-Saygi Evrim   Akyuz Gulseren   Bizargity Peyman   Ay Pinar  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 1033-1036

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

By Iwamoto Jun   Takeda Tsuyoshi   Sato Yoshihiro   Uzawa Mitsuyoshi  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 161-167

Springer Publishing Company

Access to resources Recommend Favorite

Bone Mineral Density and Biochemical Markers of Bone Turnover in Peri- and Postmenopausal Women

By De Leo V.   Ditto A.   la Marca A.   Lanzetta D.   Massafra C.   Morgante G.  

Calcified Tissue International, Vol. 66, Iss. 4, 2000-04 ,pp. : 263-267

Springer Publishing Company

Access to resources Recommend Favorite

Evidence that Treatment with Risedronate in Women with Postmenopausal Osteoporosis Affects Bone Mineralization and Bone Volume

By Fratzl Peter   Roschger Paul   Fratzl-Zelman Nadja   Paschalis Eleftherios   Phipps Roger   Klaushofer Klaus  

Calcified Tissue International, Vol. 81, Iss. 2, 2007-08 ,pp. : 73-80

Springer Publishing Company

Access to resources Recommend Favorite